The Defense Biological Product Assurance Office (DBPAO), is designated as the principal resource of high quality, validated, and standardized biological detection assays and reagents that meet the requirements of the warfighter and the Joint Biological Defense Systems, and support the biological defense community by facilitating the transition of new technologies and coordinating their advanced development, efficient production, and timely distribution. In accordance with these assignments, the DBPAO is responsible for the development, production, conformance testing, inventory management, and security of DBPAO products. DBPAO products include antibodies, polymerase chain reaction (PCR) assays, electrochemiluminescence (ECL) assays and positive controls, lateral flow immunoassays (LFI) that include handheld assays (HHA) and biological sampling kits (BSK), that are crucial to the mission of all current and future biological warfare agent detection systems.